These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29609761)

  • 1. High-Density Lipoproteins: Effects on Vascular Function and Role in the Immune Response.
    Haghikia A; Landmesser U
    Cardiol Clin; 2018 May; 36(2):317-327. PubMed ID: 29609761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
    Kratzer A; Giral H; Landmesser U
    Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
    Marcil M; O'Connell B; Krimbou L; Genest J
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein functionality in coronary artery disease.
    Kosmas CE; Christodoulidis G; Cheng JW; Vittorio TJ; Lerakis S
    Am J Med Sci; 2014 Jun; 347(6):504-8. PubMed ID: 24603157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, high-density lipoprotein and cardiovascular dysfunction.
    Haas MJ; Mooradian AD
    Curr Opin Infect Dis; 2011 Jun; 24(3):265-72. PubMed ID: 21326098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid risk factors and their role in the pathogenesis of atherosclerosis].
    Vaverková H
    Vnitr Lek; 1996 Mar; 42(3):191-6. PubMed ID: 8686209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
    Nofer JR; Walter M; Assmann G
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
    Musunuru K; Kathiresan S
    Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein function recent advances.
    Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
    J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atheroprotective effects of high-density lipoproteins.
    Assmann G; Nofer JR
    Annu Rev Med; 2003; 54():321-41. PubMed ID: 12414916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
    Nofer JR; Brodde MF; Kehrel BE
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.
    Monette JS; Hutchins PM; Ronsein GE; Wimberger J; Irwin AD; Tang C; Sara JD; Shao B; Vaisar T; Lerman A; Heinecke JW
    Circ Res; 2016 Jun; 119(1):83-90. PubMed ID: 27114438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does high-density lipoprotein protect vascular function in healthy pregnancy?
    Sulaiman WN; Caslake MJ; Delles C; Karlsson H; Mulder MT; Graham D; Freeman DJ
    Clin Sci (Lond); 2016 Apr; 130(7):491-7. PubMed ID: 26888561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiinflammatory properties of HDL.
    Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM
    Circ Res; 2004 Oct; 95(8):764-72. PubMed ID: 15486323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.